Hui Ou Yang
Gründer bei MingMed Biotechnology Co., Ltd.
Profil
Hui Ou Yang is the founder and Chief Technology Officer of MingMed Biotechnology Co., Ltd., a company founded in 2019.
Dr. Ou Yang holds an MBA from the University of California, Los Angeles, an undergraduate and graduate degree from Peking University Health Science Center, and a doctorate from the University of North Carolina at Chapel Hill.
Aktive Positionen von Hui Ou Yang
| Unternehmen | Position | Beginn |
|---|---|---|
MingMed Biotechnology Co., Ltd.
 MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Gründer | 25.11.2019 |
Ausbildung von Hui Ou Yang
| Peking University Health Science Center | Graduate Degree |
| University of North Carolina at Chapel Hill | Doctorate Degree |
| University of California, Los Angeles | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Health Technology |
